FRESENIUS MEDICAL CARE AG (FME.DE) Fundamental Analysis & Valuation
FRA:FME • DE0005785802
Current stock price
38.69 EUR
-0.96 (-2.42%)
Last:
This FME.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. FME.DE Profitability Analysis
1.1 Basic Checks
- FME had positive earnings in the past year.
- In the past year FME had a positive cash flow from operations.
- In the past 5 years FME has always been profitable.
- FME had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- FME has a better Return On Assets (3.16%) than 66.67% of its industry peers.
- FME's Return On Equity of 7.35% is in line compared to the rest of the industry. FME outperforms 50.00% of its industry peers.
- Looking at the Return On Invested Capital, with a value of 5.30%, FME is in line with its industry, outperforming 53.33% of the companies in the same industry.
- Measured over the past 3 years, the Average Return On Invested Capital for FME is below the industry average of 6.69%.
- The 3 year average ROIC (4.02%) for FME is below the current ROIC(5.30%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROIC | 5.3% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
1.3 Margins
- The Profit Margin of FME (4.98%) is better than 76.67% of its industry peers.
- FME's Profit Margin has declined in the last couple of years.
- FME has a Operating Margin of 9.00%. This is in the better half of the industry: FME outperforms 73.33% of its industry peers.
- FME's Operating Margin has declined in the last couple of years.
- FME has a Gross Margin (25.62%) which is comparable to the rest of the industry.
- FME's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% |
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
2. FME.DE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so FME is still creating some value.
- Compared to 1 year ago, FME has less shares outstanding
- The number of shares outstanding for FME has been reduced compared to 5 years ago.
- The debt/assets ratio for FME is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 1.83 indicates that FME is not a great score, but indicates only limited risk for bankruptcy at the moment.
- FME has a Altman-Z score (1.83) which is comparable to the rest of the industry.
- FME has a debt to FCF ratio of 6.19. This is a slightly negative value and a sign of low solvency as FME would need 6.19 years to pay back of all of its debts.
- FME has a Debt to FCF ratio of 6.19. This is in the better half of the industry: FME outperforms 66.67% of its industry peers.
- FME has a Debt/Equity ratio of 0.65. This is a neutral value indicating FME is somewhat dependend on debt financing.
- FME has a Debt to Equity ratio of 0.65. This is amongst the best in the industry. FME outperforms 83.33% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Altman-Z | 1.83 |
ROIC/WACC1.05
WACC5.04%
2.3 Liquidity
- FME has a Current Ratio of 1.26. This is a normal value and indicates that FME is financially healthy and should not expect problems in meeting its short term obligations.
- The Current ratio of FME (1.26) is better than 73.33% of its industry peers.
- FME has a Quick Ratio of 1.26. This is a bad value and indicates that FME is not financially healthy enough and could expect problems in meeting its short term obligations.
- FME has a Quick ratio of 0.92. This is in the better half of the industry: FME outperforms 70.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 |
3. FME.DE Growth Analysis
3.1 Past
- FME shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.00%, which is quite impressive.
- The Earnings Per Share has been decreasing by -1.51% on average over the past years.
- FME shows a small growth in Revenue. In the last year, the Revenue has grown by 1.51%.
- Measured over the past years, FME shows a small growth in Revenue. The Revenue has been growing by 1.91% on average per year.
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
3.2 Future
- Based on estimates for the next years, FME will show a quite strong growth in Earnings Per Share. The EPS will grow by 9.03% on average per year.
- Based on estimates for the next years, FME will show a small growth in Revenue. The Revenue will grow by 3.69% on average per year.
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y9.03%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. FME.DE Valuation Analysis
4.1 Price/Earnings Ratio
- A Price/Earnings ratio of 9.02 indicates a reasonable valuation of FME.
- FME's Price/Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 90.00% of the companies in the same industry.
- FME's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 27.33.
- FME is valuated reasonably with a Price/Forward Earnings ratio of 9.40.
- FME's Price/Forward Earnings ratio is rather cheap when compared to the industry. FME is cheaper than 93.33% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of FME to the average of the S&P500 Index (38.16), we can say FME is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.02 | ||
| Fwd PE | 9.4 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, FME is valued a bit cheaper than 80.00% of the companies in the same industry.
- Based on the Price/Free Cash Flow ratio, FME is valued a bit cheaper than the industry average as 80.00% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 6.51 | ||
| EV/EBITDA | 6.1 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y2.59%
EPS Next 3Y5.97%
5. FME.DE Dividend Analysis
5.1 Amount
- FME has a Yearly Dividend Yield of 3.72%. Purely for dividend investing, there may be better candidates out there.
- Compared to an average industry Dividend Yield of 1.83, FME pays a better dividend. On top of this FME pays more dividend than 96.67% of the companies listed in the same industry.
- FME's Dividend Yield is rather good when compared to the S&P500 average which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.72% |
5.2 History
- The dividend of FME has a limited annual growth rate of 4.43%.
Dividend Growth(5Y)4.43%
Div Incr Years2
Div Non Decr Years3
5.3 Sustainability
- FME pays out 43.19% of its income as dividend. This is a bit on the high side, but may be sustainable.
- The dividend of FME is growing, but earnings are growing more, so the dividend growth is sustainable.
DP43.19%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
FME.DE Fundamentals: All Metrics, Ratios and Statistics
FRA:FME (4/15/2026, 5:36:15 PM)
38.69
-0.96 (-2.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-24 2026-02-24/dmh
Earnings (Next)05-05 2026-05-05
Inst Owners44.85%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap11.35B
Revenue(TTM)19.63B
Net Income(TTM)978.37M
Analysts65.93
Price Target45.41 (17.37%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.72% |
Yearly Dividend1.48
Dividend Growth(5Y)4.43%
DP43.19%
Div Incr Years2
Div Non Decr Years3
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.86%
Min EPS beat(2)14.16%
Max EPS beat(2)35.55%
EPS beat(4)4
Avg EPS beat(4)22.94%
Min EPS beat(4)14.16%
Max EPS beat(4)35.55%
EPS beat(8)8
Avg EPS beat(8)21.57%
EPS beat(12)10
Avg EPS beat(12)16.05%
EPS beat(16)12
Avg EPS beat(16)12.94%
Revenue beat(2)1
Avg Revenue beat(2)0.93%
Min Revenue beat(2)-1.71%
Max Revenue beat(2)3.58%
Revenue beat(4)2
Avg Revenue beat(4)0.32%
Min Revenue beat(4)-3.33%
Max Revenue beat(4)3.58%
Revenue beat(8)4
Avg Revenue beat(8)-0.14%
Revenue beat(12)5
Avg Revenue beat(12)-0.25%
Revenue beat(16)7
Avg Revenue beat(16)-0.28%
PT rev (1m)-0.82%
PT rev (3m)-4.61%
EPS NQ rev (1m)-0.67%
EPS NQ rev (3m)29.57%
EPS NY rev (1m)2.65%
EPS NY rev (3m)-0.74%
Revenue NQ rev (1m)-0.71%
Revenue NQ rev (3m)-5.93%
Revenue NY rev (1m)-0.95%
Revenue NY rev (3m)-3.02%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 9.02 | ||
| Fwd PE | 9.4 | ||
| P/S | 0.58 | ||
| P/FCF | 6.51 | ||
| P/OCF | 4.23 | ||
| P/B | 0.85 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.1 |
EPS(TTM)4.29
EY11.09%
EPS(NY)4.12
Fwd EY10.64%
FCF(TTM)5.94
FCFY15.36%
OCF(TTM)9.14
OCFY23.62%
SpS66.89
BVpS45.36
TBVpS-5.17
PEG (NY)N/A
PEG (5Y)N/A
Graham Number66.1712 (71.03%)
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 3.16% | ||
| ROE | 7.35% | ||
| ROCE | 7.13% | ||
| ROIC | 5.3% | ||
| ROICexc | 5.78% | ||
| ROICexgc | 16.63% | ||
| OM | 9% | ||
| PM (TTM) | 4.98% | ||
| GM | 25.62% | ||
| FCFM | 8.88% |
ROA(3y)2.08%
ROA(5y)2.19%
ROE(3y)4.9%
ROE(5y)5.43%
ROIC(3y)4.02%
ROIC(5y)3.98%
ROICexc(3y)4.29%
ROICexc(5y)4.23%
ROICexgc(3y)11.55%
ROICexgc(5y)11.07%
ROCE(3y)5.42%
ROCE(5y)5.44%
ROICexgc growth 3Y23.76%
ROICexgc growth 5Y-0.49%
ROICexc growth 3Y19.48%
ROICexc growth 5Y-3.49%
OM growth 3Y10.69%
OM growth 5Y-6.44%
PM growth 3Y12.82%
PM growth 5Y-5.23%
GM growth 3Y0.52%
GM growth 5Y-3.74%
F-Score8
Asset Turnover0.63
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 6.19 | ||
| Debt/EBITDA | 2.64 | ||
| Cap/Depr | 62.47% | ||
| Cap/Sales | 4.78% | ||
| Interest Coverage | 4.9 | ||
| Cash Conversion | 82.09% | ||
| Profit Quality | 178.22% | ||
| Current Ratio | 1.26 | ||
| Quick Ratio | 0.92 | ||
| Altman-Z | 1.83 |
F-Score8
WACC5.04%
ROIC/WACC1.05
Cap/Depr(3y)48.17%
Cap/Depr(5y)48.21%
Cap/Sales(3y)4.06%
Cap/Sales(5y)4.23%
Profit Quality(3y)290.62%
Profit Quality(5y)248.93%
High Growth Momentum
Growth
EPS 1Y (TTM)32%
EPS 3Y11.44%
EPS 5Y-1.51%
EPS Q2Q%58.24%
EPS Next Y-4.05%
EPS Next 2Y2.59%
EPS Next 3Y5.97%
EPS Next 5Y9.03%
Revenue 1Y (TTM)1.51%
Revenue growth 3Y0.39%
Revenue growth 5Y1.91%
Sales Q2Q%-0.29%
Revenue Next Year-0.21%
Revenue Next 2Y1.76%
Revenue Next 3Y2.08%
Revenue Next 5Y3.69%
EBIT growth 1Y39.46%
EBIT growth 3Y11.12%
EBIT growth 5Y-4.66%
EBIT Next Year70.62%
EBIT Next 3Y23.59%
EBIT Next 5Y15.26%
FCF growth 1Y4.8%
FCF growth 3Y7.67%
FCF growth 5Y-11.14%
OCF growth 1Y12.36%
OCF growth 3Y7.35%
OCF growth 5Y-8.73%
FRESENIUS MEDICAL CARE AG / FME.DE Fundamental Analysis FAQ
What is the fundamental rating for FME stock?
ChartMill assigns a fundamental rating of 5 / 10 to FME.DE.
What is the valuation status for FME stock?
ChartMill assigns a valuation rating of 6 / 10 to FRESENIUS MEDICAL CARE AG (FME.DE). This can be considered as Fairly Valued.
How profitable is FRESENIUS MEDICAL CARE AG (FME.DE) stock?
FRESENIUS MEDICAL CARE AG (FME.DE) has a profitability rating of 5 / 10.
Can you provide the financial health for FME stock?
The financial health rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 5 / 10.
How sustainable is the dividend of FRESENIUS MEDICAL CARE AG (FME.DE) stock?
The dividend rating of FRESENIUS MEDICAL CARE AG (FME.DE) is 7 / 10 and the dividend payout ratio is 43.19%.